M2 Archive: Preview


You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.


Novavax signs expanded deal with India's Serum Institute for two billion COVID-19 vaccine doses

US drug and vaccine developer Novavax Inc (Nasdaq:NVAX) has stated that it is doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, Reuters news agency reported on Wednesday.

Reportedly, Novavax signed...  


If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search